HPV prevalence and genotyping in the cervix of Chinese women

Abstract

The role of human papillomavirus (HPV) as an etiologic factor of cervical cancer has been firmly established, and prophylactic vaccines are now available and have been approved in many countries. Vaccination implies a promising future for cervical cancer prevention especially for countries with very limited access to screening. However, the vaccines are not accessible in mainland China at the moment, and much needs to be understood about the potential benefit when HPV vaccines are applied to Chinese women, and to make the vaccines more specific to Chinese women. This article reviews advanced multi-center, hospital/population-based studies of most recent years, and aims to draw a definitive conclusion on HPV prevalence and genotyping in cervical cancer and precancerous lesions in China from the aspect of study population, geographic areas and time period.

Keywords

human papillomavirus (HPV) genotyping / cervical cancer / precancerous lesions / Chinese women

References

[1] ZhaoF, LiN, MaJ. Study of the association between human papillomavirus infection and cervical cancer in Xianguan county, Shanxi province. Zhonghua Liu Xing Bing Xue Za Zhi, 2001, 22(5): 375-378 (in Chinese)

[2] ShenY H, ChenF, HuangM N, LiuB, WangX X, ZhaoF H, LiS M, LiN, WuL Y, RongS D, ZhangW H, RenS D, HuangR D, QiaoY L. Population-based study of human papillomavirus infection in high-risk area for cervical cancer in Shanxi Province, China. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2003, 25(4): 381-385 (in Chinese)

[3] DaiM, BaoY P, LiN, CliffordG M, VaccarellaS, SnijdersP J, HuangR D, SunL X, MeijerC J, QiaoY L, FranceschiS. Human papillomavirus infection in Shanxi Province, People’s Republic of China: a population-based study. Br J Cancer, 2006, 95(1): 96-101

[4] WuR F, DaiM, QiaoY L, CliffordG M, LiuZ H, ArslanA, LiN, ShiJ F, SnijdersP J, MeijerC J, FranceschiS. Human papillomavirus infection in women in Shenzhen City, People’s Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer, 2007, 121(6): 1306-1311

[5] LiL K, DaiM, CliffordG M, YaoW Q, ArslanA, LiN, ShiJ F, SnijdersP J, MeijerC J, QiaoY L, FranceschiS. Human papillomavirus infection in Shenyang City, People’s Republic of China: A population-based study. Br J Cancer, 2006, 95(11): 1593-1597

[6] ZhaoF H, HuS Y, WangS M, ChenF, ZhangX, ZhangW H, PanQ J, QiaoY L. Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia. Zhongguo Yu Fang Yi Xue Zazhi, 2009, 43(7): 565-570 (in Chinese)

[7] BaoY P, LiN, WangH, QiaoY L. Study on the distribution of human papillomavirus types in cervix among Chinese women: a meta-analysis. Zhongguo Liu Xing Bing Xue Za Zhi, 2007, 28(10): 941-946 (in Chinese)

[8] StephenA L, ThompsonC H, TattersallM H, CossartY E, RoseB R. Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China. Int J Cancer, 2000, 86(5): 695-701

[9] WuY, ChenY, LiL, YuG, HeY, ZhangY. Analysis of mutations in the E6/E7 oncogenes and L1 gene of human papillomavirus 16 cervical cancer isolates from China. J Gen Virol, 2006, 87(Pt 5): 1181-1188

[10] WuY, ChenY, LiL, YuG, ZhangY, HeY. Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol, 2006, 35(3): 264-269

[11] MaimaitiA, MutallipZ, AblizG, KurbanG. The study of the relationships between HPV subtypes and Xinjiang Uygur and Han with cervical adenocarcinoma. Xinjiang Yi Ke Da Xue Xue Bao, 2009, 32(5): 6 (in Chinese)

[12] LoK W, WongY F, ChanM K, LiJ C, PoonJ S, WangV W, ZhuS N, ZhangT M, HeZ G, WuQ L, LiG D, TamJ S, KahnT, LamP, CheungT H, ChungT K. Prevalence of human papillomavirus in cervical cancer: a multicenter study in China. Int J Cancer, 2002, 100(3): 327-331

[13] ChenW, ZhangX, MolijnA, JenkinsD, ShiJ F, QuintW, SchmidtJ E, WangP, LiuY L, LiL K, ShiH, LiuJ H, XieX, NiyaziM, YangP, WeiL H, LiL Y, LiJ, LiuJ F, ZhouQ, HongY, LiL, LiQ, ZhouH L, BianM L, ChenJ, QiaoY L, SmithJ S. Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18. Cancer Causes Control, 2009, 20(9): 1705-1713

[14] BelinsonJ L, HuS, NiyaziM, PretoriusR G, WangH, WenC. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal, and vaginal self-collected specimens; implications for vaginal self-collection. Int J Cancer, 2010, 127(5): 1151-1157

[15] XieJ, QiaoH Z, WangL, MaX. Detection of human papillomavirus virus by polymerase chain reaction in cervical cancer in inner Mongolia. Neimenggu Yixue Zazhi, 2005, 37(4): 299-302 (in Chinese)

[16] WuE Q, ZhangG N, YuX H, RenY, FanY, WuY G, KongW, ZhaX. Evaluation of high-risk human papillomaviruses type distribution in cervical cancer in Sichuan province of China. BMC Cancer, 2008, 8: 202

[17] ZhangW Y, XueY Z, ChenM, HanL, LuoM. Prevalence of high-risk human papillomavirus infection in different cervical lesion among organized health-examination women in Shanghai, China. Chin Med J (Engl), 2008, 121(16): 1578-1582

[18] HongD, LvW G, YeF, ChenH Z, XieX. Detection of human papillomavirus prevalence and HPV genotypes distribution in cervical carcinoma and intraepithelial neoplasia. Xian Dai Fu Chan Ke Jin Zhan, 2006, 15(1): 36-38 (in Chinese)

[19] ChanP K, HoW C, YuM Y, PongW M, ChanA C, ChanA K, CheungT H, WongM C, ToK F, NgH K. Distribution of human papillomavirus types in cervical cancers in Hong Kong: current situation and changes over the last decades. Int J Cancer, 2009, 125(7): 1671-1677

RIGHTS & PERMISSIONS

2014 Higher Education Press and Springer-Verlag Berlin Heidelberg